1. Home
  2. KNSA vs FLNG Comparison

KNSA vs FLNG Comparison

Compare KNSA & FLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • FLNG
  • Stock Information
  • Founded
  • KNSA 2015
  • FLNG 2006
  • Country
  • KNSA United Kingdom
  • FLNG Bermuda
  • Employees
  • KNSA N/A
  • FLNG N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • FLNG Marine Transportation
  • Sector
  • KNSA Health Care
  • FLNG Consumer Discretionary
  • Exchange
  • KNSA Nasdaq
  • FLNG Nasdaq
  • Market Cap
  • KNSA 1.4B
  • FLNG 1.3B
  • IPO Year
  • KNSA 2018
  • FLNG N/A
  • Fundamental
  • Price
  • KNSA $20.02
  • FLNG $23.30
  • Analyst Decision
  • KNSA Strong Buy
  • FLNG Hold
  • Analyst Count
  • KNSA 5
  • FLNG 1
  • Target Price
  • KNSA $36.60
  • FLNG $23.00
  • AVG Volume (30 Days)
  • KNSA 567.6K
  • FLNG 491.1K
  • Earning Date
  • KNSA 02-25-2025
  • FLNG 02-04-2025
  • Dividend Yield
  • KNSA N/A
  • FLNG 12.87%
  • EPS Growth
  • KNSA N/A
  • FLNG N/A
  • EPS
  • KNSA N/A
  • FLNG 2.18
  • Revenue
  • KNSA $384,098,000.00
  • FLNG $356,349,000.00
  • Revenue This Year
  • KNSA $60.10
  • FLNG N/A
  • Revenue Next Year
  • KNSA $34.22
  • FLNG $3.58
  • P/E Ratio
  • KNSA N/A
  • FLNG $10.69
  • Revenue Growth
  • KNSA 54.41
  • FLNG N/A
  • 52 Week Low
  • KNSA $16.56
  • FLNG $20.85
  • 52 Week High
  • KNSA $28.15
  • FLNG $30.48
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 53.15
  • FLNG 39.21
  • Support Level
  • KNSA $19.31
  • FLNG $23.73
  • Resistance Level
  • KNSA $20.20
  • FLNG $24.81
  • Average True Range (ATR)
  • KNSA 0.80
  • FLNG 0.66
  • MACD
  • KNSA 0.06
  • FLNG -0.31
  • Stochastic Oscillator
  • KNSA 72.80
  • FLNG 13.48

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About FLNG FLEX LNG Ltd.

Flex LNG Ltd is an LNG shipping company with a fleet of next-generation LNG carriers with large cargo capacity. The fleet consists of thirteen modern LNG ships, ten existing and three under construction for delivery. All LNG carriers are equipped with slow-speed, two-stroke engines MEGI or X-DF propulsion which will provide Charterers with state-of-the-art tonnage offering significant advantages in form of reduced fuel consumption and lowered boil-off rates.

Share on Social Networks: